Inotuzumab Ozogamicin Injection

225 interactions 104 cited references

Also sold as: Besponsa Besponsa®

About Inotuzumab Ozogamicin Injection

Inotuzumab ozogamicin injection is used to treat certain acute lymphoblastic leukemia (ALL; a type of cancer that begins in the white blood cells) in adults who have not responded to previous cancer treatments. Inotuzumab ozogamicin injection is in a class of medications called monoclonal antibodies. It works by activa… Read the full Inotuzumab Ozogamicin Injection drug information page →

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Aug 9, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Pimozide Piperaquine Rubella Virus Vaccine, Live Saquinavir Smallpox Monkeypox Vaccine Sparfloxacin

21 Contraindicated 204 Major

All (225) Contraindicated (21) Major (204)

Major

Inotuzumab Ozogamicin Injection Buserelin Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Ceritinib Zykadia An increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Chloroquine Aralen® Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Chlorpromazine Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Cholera Vaccine Ipol An increased risk of infection by the live vaccine Details Inotuzumab Ozogamicin Injection Ciprofloxacin Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Citalopram Celexa Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Clarithromycin Biaxin Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Clomipramine Anafranil Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Clothiapine Increased risk of cardiac arrhythmias Details Inotuzumab Ozogamicin Injection Clozapine Clozaril Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Crizotinib Xalkori Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Cyclobenzaprine Amrix Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Dabrafenib Tafinlar Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Dasatinib Phyrago Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Degarelix Firmagon Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Delamanid Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Desflurane Suprane An increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Desipramine Norpramin Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Deslorelin Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Deutetrabenazine Austedo Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Dexmedetomidine Dexased Increased risk of cardiac arrhythmias Details Inotuzumab Ozogamicin Injection Disopyramide Norpace Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Dofetilide Tikosyn Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Dolasetron Anzemet Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Domperidone Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Donepezil Adlarity Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Dordaviprone An increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Doxepin Prudoxin Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Droperidol Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Ebastine Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Ebola Zaire Vaccine, Live An increased risk of infection by the live vaccine Details Inotuzumab Ozogamicin Injection Efavirenz Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Encorafenib Braftovi Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Entrectinib Rozlytrek An increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Eribulin Halaven Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Erythromycin Erythrocin Stearate Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Escitalopram Lexapro Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Etrasimod Velsipity Increased risk of transient reduction in heart rate, AV conduction, QT interval prolongation and an increased risk of torsade de p... Details Inotuzumab Ozogamicin Injection Famotidine Calmicid Increased risk of QT interval prolongation Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.